Sialic acid as a potential approach for the protection and targeting of nanocarriers
暂无分享,去创建一个
Barbara Ruozi | Giovanni Tosi | Flavio Forni | Lucia Bondioli | Daniela Belletti | Maria Angela Vandelli | B. Ruozi | G. Tosi | F. Forni | M. Vandelli | D. Belletti | L. Bondioli
[1] C. Bertozzi,et al. Chemical approaches to glycobiology and emerging carbohydrate-based therapeutic agents. , 1998, Current opinion in chemical biology.
[2] M. Sawada,et al. Effects of glycophorin and ganglioside GM3 on the blood circulation and tissue distribution of liposomes in rats , 1993 .
[3] K. Akiyoshi,et al. Interaction between ganglioside-containing liposome and rat T-lymphocyte: confocal fluorescence microscopic study. , 1994, Biochemical and biophysical research communications.
[4] A. Gabizon,et al. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[5] E. Vimr,et al. Escherichia coli K1 polysialic acid O-acetyltransferase gene, neuO, and the mechanism of capsule form variation involving a mobile contingency locus. , 2005, Proceedings of the National Academy of Sciences of the United States of America.
[6] G. Gregoriadis,et al. The effect of polysialylation on the immunogenicity and antigenicity of asparaginase: implication in its pharmacokinetics. , 2001, International journal of pharmaceutics.
[7] H. Tsukada,et al. Functional role of sialyl Lewis X and fibronectin‐derived RGDS peptide analogue on tumor‐cell arrest in lungs followed by extravasation , 1996, International journal of cancer.
[8] É. Kemertelidze,et al. Therapeutic effect of phenolic compounds isolated from Rhododendron ungernii leaves , 2007, Pharmaceutical Chemistry Journal.
[9] Deborah H. Charych,et al. Polydiacetylene liposomes functionalized with sialic acid bind and colorimetrically detect influenza virus , 1995 .
[10] M. Hirai,et al. Accumulation of liposome with Sialyl Lewis X to inflammation and tumor region: application to in vivo bio-imaging. , 2007, Biochemical and biophysical research communications.
[11] N. Strynadka,et al. Structural and Mechanistic Analysis of Sialic Acid Synthase NeuB from Neisseria meningitidis in Complex with Mn2+, Phosphoenolpyruvate, and N-Acetylmannosaminitol* , 2005, Journal of Biological Chemistry.
[12] A. Varki,et al. Chemical diversity in the sialic acids and related alpha-keto acids: an evolutionary perspective. , 2002, Chemical reviews.
[13] D. Trombetta,et al. Design and Characterization of Liposomes Containing Long-Chain N-AcylPEs for Brain Delivery: Penetration of Liposomes Incorporating GM1 into the Rat Brain , 2002, Pharmaceutical Research.
[14] 周二 小島,et al. シアル酸修飾による糖蛋白質結合リポソームの細網内皮系(RES)への取り込み抑制と促進に関する検討 , 2002 .
[15] M. Bednarski,et al. Polymerized liposomes containing C-glycosides of sialic acid: potent inhibitors of influenza virus in vitro infectivity , 1993 .
[16] G. Gregoriadis,et al. Polysialylated asparaginase: preparation, activity and pharmacokinetics. , 1997, Biochimica et biophysica acta.
[17] Roland Schauer,et al. Sialic acids as regulators of molecular and cellular interactions , 2009, Current Opinion in Structural Biology.
[18] G. Gregoriadis,et al. Improving the therapeutic efficacy of peptides and proteins: a role for polysialic acids. , 2005, International journal of pharmaceutics.
[19] M A Vandelli,et al. Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: In vivo pharmacological evidence and biodistribution. , 2010, Journal of controlled release : official journal of the Controlled Release Society.
[20] M. Kiefel,et al. Recent advances in the synthesis of sialic acid derivatives and sialylmimetics as biological probes. , 2002, Chemical reviews.
[21] Roland Schauer,et al. Sialic acids and their role as biological masks , 1985 .
[22] T. Allen,et al. Liposomes with prolonged circulation times: factors affecting uptake by reticuloendothelial and other tissues. , 1989, Biochimica et biophysica acta.
[23] L. Huang,et al. Role of liposome size and RES blockade in controlling biodistribution and tumor uptake of GM1-containing liposomes. , 1992, Biochimica et biophysica acta.
[24] E. Tamiya,et al. Amyloid-beta detection with saccharide immobilized gold nanoparticle on carbon electrode. , 2008, Bioelectrochemistry.
[25] L. Huang,et al. Large liposomes containing ganglioside GM1 accumulate effectively in spleen. , 1991, Biochimica et biophysica acta.
[26] G. Gregoriadis,et al. Polysialylated insulin: synthesis, characterization and biological activity in vivo. , 2003, Biochimica et biophysica acta.
[27] T M Allen,et al. Large unilamellar liposomes with low uptake into the reticuloendothelial system , 1987, FEBS letters.
[28] S. Pipe,et al. Strategies towards a longer acting factor VIII , 2006, Haemophilia : the official journal of the World Federation of Hemophilia.
[29] G. Whitesides,et al. The agglutination of erythrocytes by influenza virus is strongly inhibited by liposomes incorporating an analog of sialyl gangliosides , 1992 .
[30] Nicholas A Peppas,et al. Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles. , 2006, International journal of pharmaceutics.
[31] G. Tosi,et al. Nanoparticles as drug delivery agents specific for CNS: in vivo biodistribution. , 2009, Nanomedicine : nanotechnology, biology, and medicine.
[32] J. Benoit,et al. The rise and rise of stealth nanocarriers for cancer therapy: passive versus active targeting. , 2010, Nanomedicine.
[33] Wen-jie Zheng,et al. Sialic acid surface decoration enhances cellular uptake and apoptosis-inducing activity of selenium nanoparticles. , 2011, Colloids and surfaces. B, Biointerfaces.
[34] F. Dosio,et al. Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential , 2006, International journal of nanomedicine.
[35] James C Paulson,et al. In vivo targeting of B-cell lymphoma with glycan ligands of CD22. , 2010, Blood.
[36] E. Vodovozova,et al. A diglyceride derivative of methotrexate: Synthesis and cytotoxic activity in addressed liposomes , 2007, Pharmaceutical Chemistry Journal.
[37] H. Wada,et al. Activation of human T lymphocytes by ganglioside-containing liposomes , 1999, Glycoconjugate Journal.
[38] N. Chiaramoni,et al. Stability of Liposomal Formulations in Physiological Conditions for Oral Drug Delivery , 2004, Drug delivery.
[39] A. M. Lefer,et al. Cardioprotection by liposome-conjugated sialyl Lewisx-oligosaccharide in myocardial ischaemia and reperfusion injury. , 1995, Cardiovascular research.
[40] G. Tosi,et al. PLGA nanoparticles surface decorated with the sialic acid, N-acetylneuraminic acid. , 2010, Biomaterials.
[41] L. Baum,et al. Galectins: versatile modulators of cell adhesion, cell proliferation, and cell death , 1998, Journal of Molecular Medicine.
[42] J Szebeni,et al. Stealth liposomes and long circulating nanoparticles: critical issues in pharmacokinetics, opsonization and protein-binding properties. , 2003, Progress in lipid research.
[43] D. D. Ourth,et al. Bacterial sialic acid modulates activation of the alternative complement pathway of channel catfish (Ictalurus punctatus). , 1987, Developmental and comparative immunology.
[45] K. Schmid. Human plasma alpha 1-acid glycoprotein--biochemical properties, the amino acid sequence and the structure of the carbohydrate moiety, variants and polymorphism. , 1989, Progress in clinical and biological research.
[46] L. Huang,et al. The role of protein-linked oligosaccharide in the bilayer stabilization activity of glycophorin A for dioleoylphosphatidylethanolamine liposomes. , 1989, Biochimica et biophysica acta.
[47] Jinwoo Cheon,et al. Biocompatible heterostructured nanoparticles for multimodal biological detection. , 2006, Journal of the American Chemical Society.
[48] Luke S. S. Guo,et al. Sialyl Lewis x Liposomes as a Multivalent Ligand and Inhibitor of E-Selectin Mediated Cellular Adhesion , 1996 .
[49] Leaf Huang,et al. Biodistribution and Antitumor Effect of Adriamycin Encapsulated in Long-Circulating Liposomes Containing Amphipathic Polyethylene Glycol or Ganglioside GM1 , 1994 .
[50] S. Rosen. L-selectin and its biological ligands , 1993, Histochemistry.
[51] Yasutaka Matsuo,et al. Gold nanoparticle arrangement on viral particles through carbohydrate recognition: a non-cross-linking approach to optical virus detection. , 2009, Bioconjugate chemistry.
[52] G. Rougon,et al. Cell biology of polysialic acid , 1997, Current Opinion in Neurobiology.
[53] R. Cotran,et al. Identification of an inducible endothelial-leukocyte adhesion molecule. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[54] B. Seed,et al. Recognition by ELAM-1 of the sialyl-Lex determinant on myeloid and tumor cells. , 1990, Science.
[55] I. Fichtner,et al. Effect of surface modified liposomes on the aggregation of platelets and tumor cells , 2005, Thrombosis and Haemostasis.
[56] A. Varki,et al. Chemical Diversity in the Sialic Acids and Related α-Keto Acids: An Evolutionary Perspective , 2002 .
[57] G. Ashwell,et al. Ligand-induced modulation of the hepatic receptor for asialoglycoproteins. Evidence for the role of cell surface hyposialylation. , 1989, The Journal of biological chemistry.
[58] D. Pang,et al. Wheat germ agglutinin-modified trifunctional nanospheres for cell recognition. , 2007, Bioconjugate chemistry.
[59] P. Couvreur,et al. Stability of orosomucoid-coated polyisobutylcyanoacrylate nanoparticles in the presence of serum , 1996 .
[60] Sunamoto Junzo,et al. Direct transfer of tumor surface antigenic protein (TSAP) from tumor cell to liposome for making liposomal vaccine , 1992 .
[61] Jinwoo Cheon,et al. Dual-mode nanoparticle probes for high-performance magnetic resonance and fluorescence imaging of neuroblastoma. , 2006, Angewandte Chemie.
[62] F. Gage,et al. The glycans of stem cells. , 2007, Current opinion in chemical biology.
[63] Chuangui Wang,et al. Lectin-based biosensor strategy for electrochemical assay of glycan expression on living cancer cells. , 2010, Analytical chemistry.
[64] Hiroshi Yokoyama,et al. Biomedical nanotechnology for active drug delivery systems by applying sugar-chain molecular functions , 2005 .
[65] I. Fichtner,et al. Effect of sialyl Lewis X-glycoliposomes on the inhibition of E-selectin-mediated tumour cell adhesion in vitro. , 2004, Biochimica et biophysica acta.
[66] N. Bovin,et al. Antitumour activity of cytotoxic liposomes equipped with selectin ligand SiaLe(X), in a mouse mammary adenocarcinoma model. , 2000, European journal of cancer.
[67] M A Vandelli,et al. Targeting the central nervous system: in vivo experiments with peptide-derivatized nanoparticles loaded with Loperamide and Rhodamine-123. , 2007, Journal of controlled release : official journal of the Controlled Release Society.
[68] D. Salomon,et al. Novel and simple loading procedure of cisplatin into liposomes and targeting tumor endothelial cells. , 2010, International journal of pharmaceutics.
[69] G. Gregoriadis,et al. Polysialic acids: potential in drug delivery , 1993, FEBS letters.
[70] T. Brezicka,et al. Gangliosides as Therapeutic Targets for Cancer , 2012, BioDrugs.
[71] K. Higashi,et al. Effects of sialic acid derivative on long circulation time and tumor concentration of liposomes , 1995 .
[72] Barbara Ruozi,et al. Investigation on mechanisms of glycopeptide nanoparticles for drug delivery across the blood-brain barrier. , 2011, Nanomedicine.
[73] Tumor Lectinology: At the Intersection of Carbohydrate Chemistry, Biochemistry, Cell Biology, and Oncology , 1988 .